Skip to Content

125 GG 337 (Levothyroxine 125 mcg (0.125 mg))

This pill with imprint "125 GG 337" is Beige, Capsule-shape and has been identified as Levothyroxine sodium 125 mcg (0.125 mg). It is manufactured by Sandoz Pharmaceuticals Inc..

Levothyroxine is used in the treatment of underactive thyroid; hashimoto's disease; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337 Front
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337 Back
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337
Levothyroxine sodium
125 GG 337
125 mcg (0.125 mg)
9.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.